Neuroscience
Elder issues (Behavioural Sciences and the Law). A neglected area, this issue deals with things like how Alzheimer's Disease affects people's capability to make legally binding decisions, and how stereotypes about the elderly might affect legal decision makers.
Evidence-based practice in clinical psychology: Education and training issues (Journal of Clinical Psychology). This issue aims to answer questions like What is evidence-based practice in clinical psychology? Why is it important? What do you need to know?
Education and Pedagogy with Learning Objects and Learning Designs (Computers and Human Behaviour). E-learning meets psychology and pedagogy.
Behavioral and Economic Perspectives in Drug Abuse Research (Drug and Alcohol Dependence). How drug abuse is affected by economics, market forces and social environmental phenomena such as drug trafficking and distribution, gang activities, family disruption and neighborhood structure and dysfunction.
- The Special Issue Spotter
We trawl the world's journals so you don't have to: Television and toddlers: The message, the medium, and their impact on early cognitive development (Developmental Review). Multisensory processes (European Journal of Neuroscience). Linking research...
- Neuropsychology Abstract Of The Day: Alzheimer's Disease Pharmacologic Strategies
New pharmacological strategies for treatment of Alzheimer's disease: focus on disease-modifying drugs British Journal of Clinical Pharmacology. 2011 Oct 28; Salomone S, Caraci F, Leggio GM, Fedotova J, Drago F Abstract Current approved drug treatments...
- Neuropsychology Abstract Of The Day: Alzheimer's Disease Drug Development
Becker RE & Greig NH. Alzheimer's disease drug development in 2008 and beyond: Problems and opportunities. Current Alzheimer Research. 2008 Aug; 5(4): 346-357. Drug Design & Development Section, Laboratory of Neurosciences, Intramural Research Program,...
- Business World: Myriad Genetics, Flurizan (mpc-7869), And Alzheimer Disease
From the AP, via Yahoo! News: Largest-Ever Alzheimer's Drug Trial Begins By PAUL ELIAS, AP Biotechnology Writer Sun Mar 12, 6:58 AM ET SAN FRANCISCO - It's tragedy enough that Pat Williams' mother...
- Issues In Clinical Trials: Gdnf And Parkinson Disease
Today's New York Times includes a front-page article about the culture of clinical-trials research: what happens to participant subjects when an experimental drug is pulled from testing and, among other issues, how teasing apart placebo-based from...
Neuroscience
The Special Issue Spotter
Elder issues (Behavioural Sciences and the Law). A neglected area, this issue deals with things like how Alzheimer's Disease affects people's capability to make legally binding decisions, and how stereotypes about the elderly might affect legal decision makers.Evidence-based practice in clinical psychology: Education and training issues (Journal of Clinical Psychology). This issue aims to answer questions like What is evidence-based practice in clinical psychology? Why is it important? What do you need to know?
Education and Pedagogy with Learning Objects and Learning Designs (Computers and Human Behaviour). E-learning meets psychology and pedagogy.
Behavioral and Economic Perspectives in Drug Abuse Research (Drug and Alcohol Dependence). How drug abuse is affected by economics, market forces and social environmental phenomena such as drug trafficking and distribution, gang activities, family disruption and neighborhood structure and dysfunction.
- The Special Issue Spotter
We trawl the world's journals so you don't have to: Television and toddlers: The message, the medium, and their impact on early cognitive development (Developmental Review). Multisensory processes (European Journal of Neuroscience). Linking research...
- Neuropsychology Abstract Of The Day: Alzheimer's Disease Pharmacologic Strategies
New pharmacological strategies for treatment of Alzheimer's disease: focus on disease-modifying drugs British Journal of Clinical Pharmacology. 2011 Oct 28; Salomone S, Caraci F, Leggio GM, Fedotova J, Drago F Abstract Current approved drug treatments...
- Neuropsychology Abstract Of The Day: Alzheimer's Disease Drug Development
Becker RE & Greig NH. Alzheimer's disease drug development in 2008 and beyond: Problems and opportunities. Current Alzheimer Research. 2008 Aug; 5(4): 346-357. Drug Design & Development Section, Laboratory of Neurosciences, Intramural Research Program,...
- Business World: Myriad Genetics, Flurizan (mpc-7869), And Alzheimer Disease
From the AP, via Yahoo! News: Largest-Ever Alzheimer's Drug Trial Begins By PAUL ELIAS, AP Biotechnology Writer Sun Mar 12, 6:58 AM ET SAN FRANCISCO - It's tragedy enough that Pat Williams' mother...
- Issues In Clinical Trials: Gdnf And Parkinson Disease
Today's New York Times includes a front-page article about the culture of clinical-trials research: what happens to participant subjects when an experimental drug is pulled from testing and, among other issues, how teasing apart placebo-based from...